TETSUO ASHIZAWA to Receptors, Cholinergic
This is a "connection" page, showing publications TETSUO ASHIZAWA has written about Receptors, Cholinergic.
Connection Strength
0.470
-
Profile of the regions on the alpha-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol Immunol. 1992 Dec; 29(12):1507-14.
Score: 0.096
-
Autoimmune recognition profile of the alpha chain of human acetylcholine receptor in myasthenia gravis. Adv Exp Med Biol. 1991; 303:255-61.
Score: 0.084
-
False positive anti-acetylcholine receptor antibodies in motorneurone disease. Lancet. 1986 May 31; 1(8492):1272.
Score: 0.061
-
Acetylcholine receptor turnover in myasthenia gravis. Am J Physiol. 1982 Jul; 243(1):E31-6.
Score: 0.047
-
Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG. Autoimmunity. 2002 May; 35(3):183-90.
Score: 0.046
-
Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes. Ann Neurol. 1982 Jan; 11(1):22-7.
Score: 0.045
-
Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of Myasthenia gravis? Hum Immunol. 2000 Mar; 61(3):255-65.
Score: 0.040
-
Complement-dependent lysis of cultured rat myotubes by myasthenic immunoglobulins. Neurology. 1985 Dec; 35(12):1748-53.
Score: 0.015
-
Immunopathologic events at the endplate in myasthenia gravis. Springer Semin Immunopathol. 1985; 8(3):177-96.
Score: 0.014
-
The effects of carbamylcholine, calcium, and cyclic nucleotides on acetylcholine receptor synthesis in cultured myotubes. Ann N Y Acad Sci. 1981; 377:189-97.
Score: 0.011
-
Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T-cell epitope. J Neuroimmunol. 2000 Jun 26; 105(2):131-44.
Score: 0.010